Unsuspected consequences of synonymous and missense variants in OCA2 can be detected in blood cell RNA samples of patients with albinism.
OCA2
albinism
diagnosis
exon skipping
mRNA
noninvasive
variant of unknown significance
Journal
Pigment cell & melanoma research
ISSN: 1755-148X
Titre abrégé: Pigment Cell Melanoma Res
Pays: England
ID NLM: 101318927
Informations de publication
Date de publication:
31 Aug 2023
31 Aug 2023
Historique:
received:
07
07
2023
accepted:
18
08
2023
medline:
31
8
2023
pubmed:
31
8
2023
entrez:
31
8
2023
Statut:
aheadofprint
Résumé
Oculocutaneous albinism type 2 (OCA2) is the second most frequent form of albinism and represents about 30% of OCA worldwide. As with all types of OCA, patients present with hypopigmentation of hair and skin, as well as severe visual abnormalities. We focused on a subgroup of 29 patients for whom genetic diagnosis was pending because at least one of their identified variants in or around exon 10 of OCA2 is of uncertain significance (VUS). By minigene assay, we investigated the effect of these VUS on exon 10 skipping and showed that not only intronic but also some synonymous variants can result in enhanced exon skipping. We further found that excessive skipping of exon 10 could be detected directly on blood samples of patients and of their one parent with the causal variant, avoiding invasive skin biopsies. Moreover, we show that variants, which result in lack of detectable OCA2 mRNA can be identified from blood samples as well, as shown for the most common OCA2 pathogenic missense variant c.1327G>A/p.(Val443Ile). In conclusion, blood cell RNA analysis allows testing the potential effect of any OCA2 VUS on transcription products. This should help to elucidate yet unsolved OCA2 patients and improve genetic counseling.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Genespoir
Informations de copyright
© 2023 The Authors. Pigment Cell & Melanoma Research published by John Wiley & Sons Ltd.
Références
Anna, A., & Monika, G. (2018). Splicing mutations in human genetic disorders: Examples, detection, and confirmation. Journal of Applied Genetics, 59(3), 253-268. https://doi.org/10.1007/s13353-018-0444-7
Baralle, D., & Buratti, E. (2017). RNA splicing in human disease and in the clinic. Clinical Science, 131(5), 355-368. https://doi.org/10.1042/CS20160211
Baux, D., Van Goethem, C., Ardouin, O., Guignard, T., Bergougnoux, A., Koenig, M., & Roux, A.-F. (2021). MobiDetails: Online DNA variants interpretation. European Journal of Human Genetics: EJHG, 29(2), 356-360. https://doi.org/10.1038/s41431-020-00755-z
Bellono, N. W., Escobar, I. E., Lefkovith, A. J., Marks, M. S., & Oancea, E. (2014). An intracellular anion channel critical for pigmentation. eLife, 3, e04543. https://doi.org/10.7554/eLife.04543
Bournazos, A. M., Riley, L. G., Bommireddipalli, S., Ades, L., Akesson, L. S., Al-Shinnag, M., Alexander, S. I., Archibald, A. D., Balasubramaniam, S., Berman, Y., Beshay, V., Boggs, K., Bojadzieva, J., Brown, N. J., Bryen, S. J., Buckley, M. F., Chong, B., Davis, M. R., Dawes, R., … Ziolowski, A. (2022). Standardized practices for RNA diagnostics using clinically accessible specimens reclassifies 75% of putative splicing variants. Genetics in Medicine, 24(1), 130-145. https://doi.org/10.1016/j.gim.2021.09.001
Burn, T. C., Connors, T. D., Klinger, K. W., & Landes, G. M. (1995). Increased exon-trapping efficiency through modifications to the pSPL3 splicing vector. Gene, 161(2), 183-187. https://doi.org/10.1016/0378-1119(95)00223-s
Cheng, T., Orlow, S. J., & Manga, P. (2013). Loss of OCA2 disrupts the unfolded protein response and increases resistance to endoplasmic reticulum stress in melanocytes. Pigment Cell & Melanoma Research, 26(6), 826-834. https://doi.org/10.1111/pcmr.12158
Crawford, N. G., Kelly, D. E., Hansen, M. E. B., Beltrame, M. H., Fan, S., Bowman, S. L., Jewett, E., Ranciaro, A., Thompson, S., Lo, Y., Pfeifer, S. P., Jensen, J. D., Campbell, M. C., Beggs, W., Hormozdiari, F., Mpoloka, S. W., Mokone, G. G., Nyambo, T., Meskel, D. W., … Tishkoff, S. A. (2017). Loci associated with skin pigmentation identified in African populations. Science (New York, NY), 358(6365), eaan8433. https://doi.org/10.1126/science.aan8433
Gargiulo, A., Testa, F., Rossi, S., Di Iorio, V., Fecarotta, S., de Berardinis, T., Iovine, A., Magli, A., Signorini, S., Fazzi, E., Galantuomo, M. S., Fossarello, M., Montefusco, S., Ciccodicola, A., Neri, A., Macaluso, C., Simonelli, F., & Surace, E. M. (2011). Molecular and clinical characterization of albinism in a large cohort of Italian patients. Investigative Ophthalmology & Visual Science, 52(3), 1281-1289. https://doi.org/10.1167/iovs.10-6091
Hutton, S. M., & Spritz, R. A. (2008). Comprehensive analysis of Oculocutaneous albinism among non-Hispanic Caucasians shows that OCA1 is the Most prevalent OCA type. The Journal of Investigative Dermatology, 128(10), 2442-2450. https://doi.org/10.1038/jid.2008.109
Jaganathan, K., Kyriazopoulou Panagiotopoulou, S., McRae, J. F., Darbandi, S. F., Knowles, D., Li, Y. I., Kosmicki, J. A., Arbelaez, J., Cui, W., Schwartz, G. B., Chow, E. D., Kanterakis, E., Gao, H., Kia, A., Batzoglou, S., Sanders, S. J., & Farh, K. K.-H. (2019). Predicting splicing from primary sequence with deep learning. Cell, 176(3), 535-548.e24. https://doi.org/10.1016/j.cell.2018.12.015
Jaworek, T. J., Kausar, T., Bell, S. M., Tariq, N., Maqsood, M. I., Sohail, A., Ali, M., Iqbal, F., Rasool, S., Riazuddin, S., Shaikh, R. S., & Ahmed, Z. M. (2012). Molecular genetic studies and delineation of the oculocutaneous albinism phenotype in the Pakistani population. Orphanet Journal of Rare Diseases, 7, 44. https://doi.org/10.1186/1750-1172-7-44
Kamaraj, B., & Purohit, R. (2014). Mutational analysis of oculocutaneous albinism: A compact review. BioMed Research International, 2014, 905472. https://doi.org/10.1155/2014/905472
Kircher, M., Witten, D. M., Jain, P., O'Roak, B. J., Cooper, G. M., & Shendure, J. (2014). A general framework for estimating the relative pathogenicity of human genetic variants. Nature Genetics, 46(3), 310-315. https://doi.org/10.1038/ng.2892
Lasseaux, E., Plaisant, C., Michaud, V., Pennamen, P., Trimouille, A., Gaston, L., Monfermé, S., Lacombe, D., Rooryck, C., Morice-Picard, F., & Arveiler, B. (2018). Molecular characterization of a series of 990 index patients with albinism. Pigment Cell & Melanoma Research, 31, 466-474. https://doi.org/10.1111/pcmr.12688
Lee, S.-T., Nicholls, R. D., Bundey, S., Laxova, R., Musarella, M., & Spritz, R. A. (1994). Mutations of the P gene in oculocutaneous albinism, ocular albinism, and Prader-Willi syndrome plus albinism. New England Journal of Medicine, 330(8), 529-534. https://doi.org/10.1056/NEJM199402243300803
Leman, R., Parfait, B., Vidaud, D., Girodon, E., Pacot, L., Gac, G. L., Ka, C., Ferec, C., Fichou, Y., Quesnelle, C., Aucouturier, C., Muller, E., Vaur, D., Castera, L., Boulouard, F., Ricou, A., Tubeuf, H., Soukarieh, O., Gaildrat, P., … Krieger, S. (2022). SPiP: Splicing prediction pipeline, a machine learning tool for massive detection of exonic and intronic variant effect on mRNA splicing. Preprints. https://doi.org/10.22541/au.164544915.57104749/v1
Lewis, R. A. (1993). Oculocutaneous albinism type 2 - RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY. In M. P. Adam, D. B. Everman, G. M. Mirzaa, R. A. Pagon, S. E. Wallace, L. J. Bean, K. W. Gripp, & A. Amemiya (Eds.), GeneReviews®. University of Washington. http://www.ncbi.nlm.nih.gov/books/NBK1232/
Lord, J., & Baralle, D. (2021). Splicing in the diagnosis of rare disease: Advances and challenges. Frontiers in Genetics, 12, 689892. https://doi.org/10.3389/fgene.2021.689892
Mauri, L., Manfredini, E., Del Longo, A., Veniani, E., Scarcello, M., Terrana, R., Radaelli, A. E., Calò, D., Mingoia, G., Rossetti, A., Marsico, G., Mazza, M., Gesu, G. P., Cristina Patrosso, M., Penco, S., Piozzi, E., & Primignani, P. (2017). Clinical evaluation and molecular screening of a large consecutive series of albino patients. Journal of Human Genetics, 62(2), 277-290. https://doi.org/10.1038/jhg.2016.123
Oetting, W. S., Garrett, S. S., Brott, M., & King, R. A. (2005). P gene mutations associated with oculocutaneous albinism type II (OCA2). Human Mutation, 25(3), 323. https://doi.org/10.1002/humu.9318
Pagani, F., Raponi, M., & Baralle, F. E. (2005). Synonymous mutations in CFTR exon 12 affect splicing and are not neutral in evolution. Proceedings of the National Academy of Sciences of the United States of America, 102(18), 6368-6372. https://doi.org/10.1073/pnas.0502288102
Pagani, F., Stuani, C., Tzetis, M., Kanavakis, E., Efthymiadou, A., Doudounakis, S., Casals, T., & Baralle, F. E. (2003). New type of disease causing mutations: The example of the composite exonic regulatory elements of splicing in CFTR exon 12. Human Molecular Genetics, 12(10), 1111-1120. https://doi.org/10.1093/hmg/ddg131
Raponi, M., Baralle, F. E., & Pagani, F. (2007). Reduced splicing efficiency induced by synonymous substitutions may generate a substrate for natural selection of new splicing isoforms: The case of CFTR exon 12. Nucleic Acids Research, 35(2), 606-613. https://doi.org/10.1093/nar/gkl1087
Rimoldi, V., Straniero, L., Asselta, R., Mauri, L., Manfredini, E., Penco, S., Gesu, G. P., Del Longo, A., Piozzi, E., Soldà, G., & Primignani, P. (2014). Functional characterization of two novel splicing mutations in the OCA2 gene associated with oculocutaneous albinism type II. Gene, 537(1), 79-84. https://doi.org/10.1016/j.gene.2013.11.102
Rooryck, C., Morice-Picard, F., Elçioglu, N. H., Lacombe, D., Taieb, A., & Arveiler, B. (2008). Molecular diagnosis of oculocutaneous albinism: new mutations in the OCA1-4 genes and practical aspects. Pigment Cell & Melanoma Research, 21(5), 583-587. https://doi.org/10.1111/j.1755-148X.2008.00496.x
Sviderskaya, E. V., Bennett, D. C., Ho, L., Bailin, T., Lee, S.-T., & Spritz, R. A. (1997). Complementation of hypopigmentation in p-mutant (pink-eyed dilution) mouse melanocytes by Normal human P cDNA, and defective complementation by OCA2 mutant sequences. Journal of Investigative Dermatology, 108(1), 30-34. https://doi.org/10.1111/1523-1747.ep12285621